Adjuvant Analgesics

On this page

Adjuvant Basics - Pain's Sidekicks

  • Definition: Drugs with primary indications other than pain, but enhance analgesia or manage analgesic side effects.
  • Purpose:
    • Improve efficacy of primary analgesics (opioids, NSAIDs).
    • Provide analgesia in specific pain types (e.g., neuropathic).
    • Reduce side effects of primary analgesics, allowing dose reduction.
  • Key Categories:
    • Antidepressants (TCAs, SNRIs)
    • Anticonvulsants (Gabapentinoids)
    • Corticosteroids
    • NMDA Antagonists (Ketamine)
    • Alpha-2 Agonists (Clonidine)

⭐ Adjuvant analgesics are primarily indicated for conditions other than pain but provide analgesia in specific pain states, especially neuropathic pain.

Antidepressants & Anticonvulsants - Nerve Calm Crew

  • Antidepressants (Neuropathic Pain)
    • TCAs (Amitriptyline, Nortriptyline)
      • Mech: ↑NE/5-HT, Na+ block.
      • Amitriptyline: 10-25mg HS to 75-150mg.
      • SEs: Anticholinergic, sedation. 📌 "Tri-CyclicS": Sedation, Cardiac, antiSlud.
      • Nortriptyline: Often better tolerated.
    • SNRIs (Duloxetine, Venlafaxine)
      • Mech: ↑NE/5-HT.
      • Duloxetine: 30-60mg/d (diabetic neuropathy).
      • Venlafaxine: 75-225mg/d.
      • SEs: Nausea, dizziness.
  • Anticonvulsants (Neuropathic Pain)
    • Gabapentinoids (Gabapentin, Pregabalin)
      • Mech: α2δ Ca2+ channel ligand.
      • Gabapentin: 100-300mg TDS to 3600mg/d.
      • Pregabalin: 25-75mg BD/TDS to 300-600mg/d.
      • SEs: Dizziness, somnolence, edema.
    • Carbamazepine
      • Trigeminal Neuralgia DOC. Dose: 200-1200mg/d.
      • ⚠️ Monitor: Agranulocytosis.

⭐ Amitriptyline (TCA) is often a first-line adjuvant for neuropathic pain, but its anticholinergic side effects limit use; Pregabalin often preferred for better tolerability.

Steroids & NMDA Blockers - Pathway Modulators

  • Corticosteroids (e.g., Dexamethasone, Prednisolone)

    • Mechanism: Potent anti-inflammatory; ↓ edema, ↓ ectopic neuronal firing. Inhibit phospholipase A2.
    • Uses: Neuropathic pain (nerve compression, tumor infiltration), inflammatory pain, cancer pain.
    • Dexamethasone: 4-8 mg BD/TDS for nerve compression pain, then taper.
    • Side Effects (long-term): Hyperglycemia, immunosuppression.

    ⭐ Dexamethasone is particularly useful for pain from nerve compression by tumors due to its potent anti-inflammatory and edema-reducing effects.

  • NMDA Receptor Antagonists (e.g., Ketamine, Memantine)

    • Mechanism: Block NMDA receptors in dorsal horn; ↓ central sensitization, wind-up, opioid tolerance.
    • Uses: Neuropathic pain, opioid-resistant pain, CRPS, phantom limb pain.
    • Ketamine: Sub-anesthetic dose (e.g., 0.1-0.5 mg/kg IV). Risk: psychomimetic effects.
    • Memantine: Oral, 5-20 mg/day. Better tolerated, less potent.

α2-Agonists & Topicals - Targeted Relief

  • α2-Adrenergic Agonists
    • Clonidine: Oral, transdermal, epidural. Reduces sympathetic tone, opioid-sparing.
    • Dexmedetomidine: IV. Highly selective. Sedation, analgesia.
    • Common Side Effects: Hypotension, bradycardia, sedation.

    ⭐ Clonidine, an alpha-2 agonist, can potentiate opioid analgesia and reduce opioid requirements, useful in managing chronic pain and opioid tolerance.

  • Topical Agents (Local Action, ↓ Systemic AEs)
    • NSAIDs (e.g., Diclofenac gel): Osteoarthritis, sprains.
    • Capsaicin cream/patch: Neuropathic pain (postherpetic neuralgia). Depletes substance P. 📌 "Capsaicin burns P(ain) away."
    • Lidocaine 5% patch: Postherpetic neuralgia, localized neuropathic pain.

High‑Yield Points - ⚡ Biggest Takeaways

  • TCAs (amitriptyline) & SNRIs (duloxetine) are first-line for neuropathic pain.
  • Gabapentinoids (gabapentin, pregabalin) are crucial for neuropathic pain and fibromyalgia.
  • Corticosteroids (dexamethasone) reduce inflammatory and nerve compression pain.
  • Ketamine (NMDA antagonist) targets central sensitization and opioid-refractory pain.
  • Alpha-2 agonists (clonidine) aid in neuropathic pain and opioid sparing.
  • Bisphosphonates (zoledronate) manage cancer-related bone pain.
  • Topical lidocaine provides relief for localized neuropathic pain like Postherpetic Neuralgia (PHN).

Unlock the full lesson and continue reading

Signup to continue reading this lesson and unlimited access questions, flashcards, AI notes, and more

Scan to download app

Scan to download
UNLOCK FREE ACCESS

Practice Questions: Adjuvant Analgesics

  1. 1. Which of the following drugs is used for smoking cessation?

    • A. Gabapentin
    • B. Acamprosate
    • C. Nalmefene
    • D. Varenicline
    Show answer

    Answer: D. Varenicline

    Varenicline - Varenicline is a partial agonist at the α4β2 nicotinic acetylcholine receptor, reducing cravings and withdrawal symptoms. - It also decreases nicotine’s rewarding effects and is a first-line pharmacotherapy for smoking cessation, often started about one week before the quit date. Acamprosate - Acamprosate is used to maintain abstinence from alcohol in patients with alcohol dependence, not to treat nicotine dependence. - Its effects help restore the balance between neuronal excitation and inhibition during alcohol abstinence, making it unsuitable for smoking cessation. Gabapentin - Gabapentin is primarily an anticonvulsant and is also used for neuropathic pain, rather than as a standard smoking-cessation drug. - Gabapentin binds α2δ subunits of voltage-gated calcium channels and has no established role as a standard smoking-cessation medicine. Nalmefene - Nalmefene is an opioid system modulator used to reduce alcohol consumption in adults with alcohol dependence, not for smoking cessation. - As an opioid receptor antagonist, its mechanism differs from the nicotinic receptor actions targeted in nicotine dependence.

  2. 2. Benzodiazepines differ from barbiturates in all the following aspects EXCEPT:

    • A. Higher therapeutic index
    • B. Lower abuse liability
    • C. Steeper dose-response curve
    • D. No microsomal enzyme induction
    Show answer

    Answer: C. Steeper dose-response curve

    Steeper dose-response curve - Benzodiazepines have a flatter dose-response curve, because they facilitate GABA action and require endogenous GABA for their effect. - A steeper dose-response curve is characteristic of barbiturates, which can directly prolong GABA-A chloride-channel opening at high doses and cause coma or death. No microsomal enzyme induction - Benzodiazepines generally do not induce hepatic microsomal drug-metabolizing enzymes, unlike barbiturates, which are potent enzyme inducers. - This difference contributes to fewer drug interactions with benzodiazepines, whereas barbiturates can reduce the effectiveness of drugs such as warfarin and oral contraceptives. Higher therapeutic index - Benzodiazepines have a higher therapeutic index because their CNS-depressant effect has a ceiling when endogenous GABA-mediated activity is limited. - This produces greater overdose safety than barbiturates, which can cause progressive respiratory and CNS depression at increasing doses. Lower abuse liability - Benzodiazepines generally have lower abuse liability and less severe withdrawal than barbiturates, although dependence and misuse can still occur. - Barbiturates produce more profound physical dependence and have a narrower safety margin, making this a valid distinction between the two drug classes.

  3. 3. Antidote for acetaminophen poisoning is?

    • A. Atropine
    • B. D-penicillamine
    • C. Acetylcysteine
    • D. Fomepizole
    Show answer

    Answer: C. Acetylcysteine

    Acetylcysteine is the established antidote for acetaminophen poisoning because it restores glutathione-dependent detoxification of NAPQI. Fomepizole is established for toxic alcohol poisoning and may be used off-label as an adjunct in selected severe acetaminophen overdoses, but it does not replace acetylcysteine. Atropine treats muscarinic manifestations of organophosphorus poisoning rather than glutathione depletion. D-penicillamine is a copper chelator and does not treat NAPQI-mediated toxicity.

  4. 4. Which drug lowers uric acid by inhibiting xanthine oxidase?

    • A. Sulfinpyrazone
    • B. Allopurinol
    • C. Probenecid
    • D. Rasburicase
    Show answer

    Answer: B. Allopurinol

    Allopurinol inhibits xanthine oxidase, reducing uric acid synthesis. Sulfinpyrazone is a uricosuric drug that increases renal urate excretion. Probenecid also increases renal urate excretion rather than inhibiting uric acid synthesis. Rasburicase is a urate oxidase that converts uric acid to allantoin.

  5. 5. Which of the following actions is NOT associated with tricyclic antidepressants?

    • A. 5-HT/NE reuptake blockade
    • B. Sedation
    • C. MAO inhibition
    • D. Anticholinergic action
    Show answer

    Answer: C. MAO inhibition

    MAO inhibition - TCAs do not primarily inhibit monoamine oxidase (MAO); their main mechanism is blockade of serotonin and norepinephrine reuptake. - MAO inhibitors are a distinct antidepressant class with a different mechanism and adverse-effect profile, so MAO inhibition is not associated with TCAs. Anticholinergic action - TCAs commonly produce anticholinergic effects by blocking muscarinic receptors, causing dry mouth, constipation, blurred vision, and related adverse effects. - This action is especially clinically important in elderly patients, who may be more susceptible to anticholinergic adverse effects. 5-HT/NE reuptake blockade - TCAs primarily inhibit the reuptake of serotonin (5-HT) and norepinephrine (NE) into presynaptic neurons. - Blocking reuptake increases neurotransmitter concentrations in the synaptic cleft, potentiating serotonergic and noradrenergic effects. Sedation - TCAs frequently cause sedation, particularly agents with prominent antihistaminic activity such as amitriptyline and doxepin. - Sedation results mainly from histamine H1 receptor antagonism; it may help insomnia but impair daytime functioning.

  6. 6. Which option best describes the traditional striatal neurotransmitter rationale for pharmacological treatment of motor symptoms in idiopathic Parkinson disease?

    • A. Suppress striatal dopamine synthesis
    • B. Block striatal dopamine receptors
    • C. Enhance striatal serotonin neurotransmission
    • D. Restore dopamine–acetylcholine balance
    Show answer

    Answer: D. Restore dopamine–acetylcholine balance

    Restore dopamine–acetylcholine balance - In idiopathic Parkinson disease, dopamine deficiency in the nigrostriatal pathway produces relative cholinergic predominance within the striatum, providing the traditional neurochemical rationale for pharmacological treatment of motor symptoms. - Levodopa increases dopamine synthesis, dopamine agonists stimulate dopamine receptors, and central antimuscarinics reduce cholinergic activity in selected patients. - Restoring the dopamine–acetylcholine balance describes this traditional rationale, not a claim that every treatment directly normalises measured neurotransmitter concentrations. Block striatal dopamine receptors - Dopamine antagonism further reduces dopaminergic effects in the nigrostriatal pathway and therefore worsens parkinsonian motor symptoms. - Dopamine-blocking antipsychotics can produce drug-induced parkinsonism, demonstrating why antagonism is not the therapeutic goal. Enhance striatal serotonin neurotransmission - Serotonin is not the principal neurotransmitter involved in the motor pathway dysfunction underlying Parkinsonism. - Although serotonergic mechanisms may influence some non-motor symptoms, treatment primarily targets the dopaminergic–cholinergic imbalance. Suppress striatal dopamine synthesis - Suppress striatal dopamine synthesis would worsen nigrostriatal dopamine deficiency rather than treat parkinsonian motor symptoms

  7. 7. Which is a GABA transaminase inhibitor?

    • A. Valproate
    • B. Lamotrigine
    • C. Gabapentin
    • D. Carbamazepine
    Show answer

    Answer: A. Valproate

    Valproate increases GABA availability partly by inhibiting its degradation, including GABA transaminase inhibition. Lamotrigine primarily inhibits voltage-gated sodium channels and reduces excitatory transmitter release rather than inhibiting GABA transaminase. Gabapentin binds the α2δ subunit of voltage-gated calcium channels rather than directly inhibiting GABA transaminase. Carbamazepine primarily produces use-dependent blockade of voltage-gated sodium channels rather than inhibiting GABA transaminase.

  8. 8. Which of the following graphs of cardiac action potential represents mechanism of action of lignocaine?

    • A. Second graph from the left
    • B. Fourth graph from the left
    • C. Third graph from the left
    • D. First graph from the left
    Show answer

    Answer: A. Second graph from the left

    Second graph from the left represents lignocaine, a class-IB sodium-channel blocker that shortens ventricular action-potential duration and can reduce phase-0 upstroke velocity, particularly in depolarized tissue. First graph from the left represents a class-IA pattern, combining phase-0 depression with action-potential prolongation. Third graph from the left represents a class-III pattern, with prolonged repolarization and relatively preserved phase 0. Fourth graph from the left represents a class-IC pattern, with marked phase-0 depression and little change in action-potential duration.

  9. 9. A 28-year-old man without a bleeding disorder presents with six months of ankle pain and swelling. MRI showed a lobulated synovial mass with low signal on T1- and T2-weighted images and blooming on gradient-echo sequences. What is your diagnosis?

    • A. Hemophilic intraosseous pseudotumor
    • B. Pigmented villonodular synovitis
    • C. Giant cell tumor of bone
    • D. Alkaptonuric ochronosis
    Show answer

    Answer: B. Pigmented villonodular synovitis

    Pigmented villonodular synovitis is the most likely diagnosis: a lobulated synovial mass with low signal on T1- and T2-weighted images and blooming on gradient-echo sequences supports hemosiderin-rich synovial proliferation. As described in Resnick and Kransdorf's Bone and Joint Imaging, hemosiderin produces low MRI signal and susceptibility blooming in both PVNS and hemophilia-associated synovitis; blooming alone is not specific. The absence of a bleeding disorder reduces concern for hemophilia-associated synovitis. Hemophilic intraosseous pseudotumor is an encapsulated hematoma resulting from recurrent hemorrhage rather than a proliferative synovial mass. Giant cell tumor of bone typically involves the epiphysis after skeletal maturity rather than the synovium. Alkaptonuric ochronosis causes pigment deposition and degenerative arthropathy rather than a hemosiderin-rich synovial mass.

  10. 10. Which of the following anesthetics is known to increase intraocular pressure?

    • A. Propofol
    • B. Alfentanil
    • C. Ketamine
    • D. Thiopental
    Show answer

    Answer: C. Ketamine

    Ketamine - Ketamine is the traditional examination answer because it may increase intraocular pressure. The effect depends on factors including dose and clinical setting, and ketamine is not universally contraindicated for all ophthalmic procedures. - This increase results from enhanced sympathetic activity and increased extraocular muscle tone, distinguishing ketamine from the other listed agents. Propofol - Propofol generally decreases intraocular pressure, making it a favorable anesthetic for ophthalmic procedures rather than an agent that increases IOP. - Its reduction in IOP is associated with decreased cerebral blood flow and inhibition of aqueous humor production, so it does not fit the question. Alfentanil - Alfentanil generally has minimal effect on intraocular pressure, unlike the anesthetic associated with increased IOP. - As an opioid, its main effects are analgesia and sedation, without a significant direct influence on oculomotor tone or ocular fluid dynamics. Thiopental - Thiopental typically reduces intraocular pressure, so it does not explain an increase in IOP. - As a barbiturate, it decreases cerebral blood flow and metabolic rate, effects associated with lowered rather than elevated intraocular pressure.

Flashcards: Adjuvant Analgesics

  1. 1. used for pain relief is based on the gate control theory of pain

    Show answer

    Transcutaneous electrical nerve stimulation (TENS)

  2. 2. Transcutaneous electrical nerve stimulation (TENS) also increases levels of neurotransmitters such as _____ and _____

    Show answer

    endorphins · enkephalins

  3. 3. What kind of pain (musculoskeletal/neurogenic) can be managed using transcutaneous electrical nerve stimulation (TENS)?

    Show answer

    Both

  4. 4. What is the main disadvantage of cryotherapy (cryoneurolysis)?

    Show answer

    Post-procedure neuralgia (Neuritis)

  5. 5. block is used for pain relief in chronic pancreatitis as well as pancreatic carcinoma

    Show answer

    Celiac plexus

  6. 6. TENS is contraindicated in patients with

    Show answer

    pacemakers

  7. 7. is an IV anesthetic that can be used to reduce postoperative pain

    Show answer

    Ketamine

  8. 8. The concentration of bupivacaine used in post-operative analgesia is %.

    Show answer

    0.1-0.25

Everything you need for Indian Medical PG prep

Get full Oncourse access with lessons, practice questions, flashcards and AI study tools.

GET STARTED FOR FREE
75% OFFLimited time offer
GET 75% OFF